Opioid withdrawal after stopping or losing access

Opioid withdrawal after stopping or losing access is both a physical and psychological state and a force shaping the wider opioid epidemic in Dopesick. The book describes how the prospect of withdrawal can make avoiding it more urgent than other considerations, drawing people back to drugs, into user-selling networks, and toward risky attempts to find a new supply. It also traces a longer history in which medical confidence in opioids repeatedly outpaced attention to dependence, while later treatment options remained difficult to access.

A Recognized Danger, Repeatedly Overlooked

In the early nineteenth century, Friedrich Sertürner isolated morphine from opium and recognized that it was far more powerful than processed opium. He observed a progression from euphoria to depression and nausea, and saw that dogs given the compound could later awaken in an agitated state with fever and diarrhea. The symptoms recalled a withdrawal state that people addicted to opium in China called yen. In 1810, Sertürner warned that the substance could have terrible effects. Decades later, Alexander Wood promoted the hypodermic needle with the mistaken assurance that injecting morphine would avoid the addiction associated with smoking or swallowing it. The book places that claim in a recurring history of new drug technologies and medical optimism obscuring known risks.

A similar confidence accompanied OxyContin. Purdue Pharma representative David Haddox promoted the drug as safe and reliable for a wide range of chronic pain, reporting an addiction risk of one-half of 1 percent when patients followed directions. The claim formed part of a larger change in medical practice: pain became the fifth vital sign, and in 1999 the Joint Commission on Accreditation of Healthcare Organizations approved mandatory pain-assessment and treatment standards. Purdue Pharma saw an opportunity to position itself as a resource for hospitals responding to those standards. Its plans included branded pain-assessment materials, while loosened pharmaceutical advertising rules and expanding promotional activity encouraged a culture in which medication was presented as a solution to many kinds of suffering.

The book also examines the limits of measuring pain through patient ratings. A pain scale could make assessment appear consistent, yet a subjective score did not establish a uniform level of need. The standards left the meaning of adequate relief unresolved, and reliance on pain scales did not necessarily improve outcomes. The account links this framework to increased opioid prescribing and abuse. Withdrawal appears within this history not as an isolated personal failing but as one consequence of a medical culture that expanded exposure to opioids while underestimating the risks of dependence.

The Immediate Pressure to Find a Supply

The recurring logic of withdrawal is clearest in the account of Woodstock, Virginia. After Ronnie Jones arrived in 2012, people who had begun with pills moved to heroin and, in some cases, sold part of what they bought to finance the next purchase. The book describes this as a cycle organized around avoiding the severe physical and psychological pain of withdrawal. Users recruit new customers, who may recruit others; the network can grow even when those involved are not trying to build a lucrative business. Some sell drugs principally to maintain their own supply.

The interruption of supply made that pressure visible on a regional scale. After Ronnie Jones was arrested in 2013, hundreds of newly addicted users in Woodstock faced a sudden shortage. Some began carpooling to Baltimore, Washington, and Martinsburg, West Virginia, to find heroin, exposing themselves to unpredictable sources and products. The book describes how a disruption in one local supply could redirect dependent users toward distant drug markets rather than end their need for opioids.

The same dependence shaped the reach of earlier heroin networks. Clifton “Lite” Lee’s operation brought large quantities into the region, and the first bags sold in Roanoke included products marked Funeral and Green Frog. Some had a purity of 90 percent. As Lee was sentenced to eleven years in prison in 2008, investigators had attributed to his network repeated shipments of a thousand bags, two to three times each week. Prosecutor Don Wolthuis worried that arrests would not eliminate demand: user-sellers could travel to Baltimore, Richmond, or Paterson, New Jersey, to replenish their supply. The distinction mattered. Arrest could remove a dealer, but it did not relieve withdrawal or erase the incentive to find another source.

Withdrawal in Individual Lives

Drenna Banks recalled a progression from prescription use to dependence and withdrawal. When her prescriptions ran out, she experienced vomiting, diarrhea, severe aches, irritability, shaking, and sleeplessness. Her account conveys how withdrawal could overwhelm ordinary judgment and make relief the immediate priority. In another case, Arnold Fayne McCauley described buying street OxyContin after his physician reduced his prescribed dose from 40 milligrams to 20. He reported nervousness, diarrhea, sweating, and a crawling sensation in his skin. He told lawyers that he bought the pills to stave off withdrawal. His experience illustrates how an attempt to reduce medication could become entangled with the illicit market when dependence had already taken hold.

The book also records how withdrawal shaped decisions within Jesse Bolstridge’s family. Jesse had attended rehabilitation in Florida, where he briefly received Suboxone, but was tapered off it after three weeks. Later, after returning to work in construction, he admitted to Kristi Fernandez that he could not stop using and was spending $200 a day on black-market opioids. He asked for help returning to treatment. Two days before the planned flight to Jacksonville, Jesse and Dennis Painter, who was already in withdrawal, stole insulin needles from Jesse’s grandmother and bought heroin. Jesse had been using black-market pills and was also experiencing withdrawal symptoms. The episode shows how a treatment plan and a family’s effort to arrange a return to care could be overtaken by the immediate need to obtain drugs.

In 2015, Tess Henry said she was already in withdrawal when she was arrested for shoplifting a plumbing item at a Roanoke Lowe’s. Later, while pregnant, she entered the Life Center of Galax, one of the few Virginia facilities then accepting patients receiving medication-assisted treatment. She took Subutex, a form of Buprenorphine recommended for some pregnant patients. The treatment helped her feel normal and prevented withdrawal, but access depended on insurance, substantial upfront expenses, and repeated cash-only physician visits. Her story makes the state visible not only through symptoms but through the practical conditions that determine whether medication can continue.

Treatment, Access, and the Meaning of Recovery

The book distinguishes ongoing medication treatment from short detoxification programs. Nora Volkow, director of the National Institute on Drug Abuse, stated that evidence supported long-term maintenance with medication alongside behavioral treatment and recovery support, rather than short-term detoxification aimed at abstinence. Jesse’s brief course of Suboxone, followed by a taper, stands in contrast to that approach. Tess’s use of Subutex likewise shows how medication could reduce withdrawal and cravings while leaving patients dependent on a system of appointments and payment to sustain care.

Those barriers extended beyond individual families. At the time described, federal rules capped the number of patients a certified medication-assisted-treatment doctor could treat at 100; the limit was later raised to 275. Tess’s buprenorphine medication was largely covered by insurance, but her addiction doctor required $700 upfront and $90 to $100 for each follow-up visit, with as many as four visits in a month. Waiting lists further narrowed access. In 2017, Hughes Melton worked with state Medicaid officials to broaden reimbursement and include counseling and care coordination, partly to encourage clinics that had operated on a cash-only basis to accept insurance. The expansion was gradual, and the need for treatment was recognized more quickly than services reached most communities.

The Hope Initiative offered one response to the difficulty of moving from crisis to sustained care. Its volunteers assembled a five-page spreadsheet listing 36 rehabilitation and aftercare providers across the southeastern United States, with referrals shaped by patients’ finances and available beds. Some volunteers also helped arrange outpatient medication-assisted treatment, though participants disagreed about its role. In Roanoke, people could meet trained volunteers at the Bradley Free Clinic on the second Monday of each month; the volunteers helped troubleshoot care, while social service workers assisted eligible patients with Medicaid applications. The initiative treated access as a series of practical hurdles, not simply a matter of willingness to recover.

Withdrawal therefore links the book’s intimate accounts to its institutional argument. A heroin supply may be interrupted by an arrest, and a prescription may be reduced or ended, but dependence leaves people with a powerful reason to seek another dose. When medication-assisted treatment is short, costly, or unavailable, the consequences can include renewed use and movement into illicit supply networks. The book’s accounts of families, dealers, clinicians, and treatment advocates show why understanding withdrawal requires attention both to the condition itself and to the systems that determine whether relief and longer-term care are within reach.